Versatile copurification procedure for rapid isolation of homogeneous RAR-RXR heterodimers

Protein Expression and Purification

Volumn 16, Issue 2, 1999, Pages 308-314

  Iyer, Jaya ^a   Bonnier, Dominique ^a   Granger, Florence ^a   Iltis, Carole ^a   Andry, Virginie ^a   Schultz, Patrick ^a   Gronemeyer, Hinrich ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; ELECTRON MICROSCOPY; PROTEIN DNA INTERACTION; PROTEIN PURIFICATION;

EID: 0033166916     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1999.1053     Document Type: Article

References (36)

1. Gronemeyer H., Laudet V. Transcription factors 3: Nuclear receptors. Protein Profile. 2:1995;1173-1308.
2. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;940-954.
3. Kastner P., Mark M., Chambon P. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell. 83:1995;859-869.
4. Mangelsdorf D. J., Evans R. M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
5. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M. The nuclear receptor superfamily: The second decade. Cell. 83:1995;835-839.
6. Moras D., Gronemeyer H. The nuclear receptor ligand binding domain: Structure and function. Curr. Opin. Cell Biol. 10:1998;384-391.
7. Luisi B. F., Xu W. X., Otwinowski Z., Freedman L. P., Yamamoto K. R, Sigler P. B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 352:1991;497-505.
8. Schwabe J. W. R., Chapman L Finch J. T., Rhodes D. Solution structure of the DNA-binding domain of the oestrogen receptor. Cell. 75:1993;567-578.
9. Rastinejad F., Perlmann T., Evans R. M., Sigler P. B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature. 375:1995;203-211.
10. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α Nature. 375:1995;377-382.
11. Renaud J. P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature. 378:1995;681-689.
12. Wagner R. L., Apriletti J. W., McGrath M. E., West B. L., Baxter J. D., Fletterick R. J. A structural role for hormone in the thyroid hormone receptor. Nature. 375:1995;640-697.
13. Brzozowski AM., Pike A. C. W., Dauter Z., Hubbard R. E., Bonn T., Engstrom O., Ohman L., Greene G. L., Gustafsson J. A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
14. Williams S. P., Sigler P. B. Atomic structure of progesterone complexed with its receptor. Nature. 393:1998;392-396.
15. Tannenbaum D. M., Wang Y., Williams S. P., Sigler P. B. Crystallographic comparison of the estrogen and progesterone receptors' ligand binding domains. Proc. Natl. Acad. Sci. USA. 95:1998;5998-6003.
16. Wurtz J. M., Bourguet W., Renaud J. P., Vivat V., Chambon P., Moras D., Gronemeyer H. A canonical structure of the ligand binding domain of nuclear receptors. Nat. Struct. Biol. 3:1996;87-94.
17. Torchia J., Glass C., Rosenfeld M. G. Co-activators and co-repressors in the integration of transcriptional response. Curr. Opin. Cell Biol. 10:1998;373-383.
18. Jenster G. Coactivators and corepressor as mediator of nuclear receptor function. An update. Mol. Cell. Endo. 143:1998;1-7.
19. Darimont B. D., Wagner R. L., Apriletti J. W., Stallup M. R., Kushner P. J., Baxter J. D., Fletterick R. J., Yamamoto K. R. Structure and specificity of nuclear receptor-coactivator interaction. Genes Dev. 12:1998;3343-3356.
20. Nolte R. T., Wisely G. B., Westin S., Cobbs J. E., Lambert M. H., Kurokawa R., Rosenfeld M. G., Willson T. M., Glass C. K., Milburn M. V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ Nature. 395:1998;137-143.
21. Vivat V., Zechel C., Wurtz J. M., Bourguet W., Kagechika H., Umemiya H., Shudo K., Moras D., Gronemeyer H., Chambon P. A mutation mimics the ligand-induced transconformation of the retinoid X receptor. EMBO J. 16:1997;5697-5709.
22. Schulman I. G., Chuan Li, Schwabe J. W. R., Evans R. M. The Phantom ligand effect; allosteric control of transcription by the retinoid X receptor. Genes Dev. 11:1997;299-308.
23. Forman B. M., Umesono K., Chen J., Evans R. M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 81:1995;541-550.
24. Perlmann T., Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGF1-B and NURR1. Genes Dev. 9:1995;769-782.
25. Kurokawa R., DiRenzo J., Boehm M., Sugarman J., Gloss B., Rosenfeld M. G., Heyman R. A., Glass C. K. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature. 371:1994;528-531.
26. Chen Z. P., Iyer J., Bourguet W., Held P., Mioskowski C., Lebeau L., Noy N., Chambon P., Gronemeyer H. Ligand and DNA- induced dissociation of RXR tetramers. J. Mol. Biol. 275:1998;55-65.
27. Tian K-T., Norris A. W., Liu C. L. S., Li E. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains. Biochemistry. 36:1997;5669-5676.
28. Li C., Schwabe J. W. R., Banayo E., Evans R. M. Coexpression of nuclear receptor partners increases their solubility and biological activities. Proc. Natl. Acad. Sci. USA. 94:1997;2278-2283.
29. Rochel N., Renaud J. P., Ruff M., Vivat V., Granger F., Bonnier D., Lerouge T., Chambon P., Gronemeyer H., Moras D. Purification of the human RAR ligand binding domain and the crystallization of its complex with all-trans retinoic acid. Biochem. Biophys. Res. Commun. 230:1997;293-296.
30. Bouguet W., Ruff M., Bonnier D., Granger F., Boeglin M., Chambon P., Moras D, Gronemeyer H. Purification, functional characterization and crystallization of the ligand binding domain of the retinoid X receptor. Protein Express. Purif. 6:1995;604-608.
31. Chen Z-P., Shemshedini L., Durand L., Noy N., Chambon P., Gronemeyer H. Pure and functionally homogeneous recombinant retinoid X receptor. J. Biol. Chem. 269:1994;25770-25776.
32. Kersten S., Kelleher D., Chambon P., Gronemeyer H., Noy N. Retinoid X receptor α forms tetramers in solution. Proc. Natl. Acad. Sci. USA. 92:1995;8645-8649.
33. Mader S., Chen. J. Y., Chen Z. P., White J., Chambon P., Gronemeyer H. The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificities of the DNA binding domains. EMBO J. 12:1993;5029-5041.
34. Kersten S., Pan L., Chambon P., Gronemeyer H., Noy N. Role of ligand in retinoid signalling: 9-Cis retinoic acid modulates the oligomeric state of the retinoid X receptor. Biochemistry. 34:1995;13717-13721.
35. Kersten S., Dawson M. I., Lewis B. A., Noy N. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently. Biochemistry. 35:1996;3816-3824.
36. Westin S., Kurokawa R, Nolte R. T., Wisely G. B., Mclnerney E. M., Rose D. W., Milburn M. V., Rosenfeld M. G., Glass C. K. Interactions controlling the assembly of nuclear receptor heterodimers and coactivators. Nature. 395:1998;199-202.